Supplement Article

Recently published articles about Supplement Article

The GABA Pathway and New Clinical Trial Data in MDD and PPD

March 16, 2023

Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD.

Kristina M. Deligiannidis, Anita H. Clayton

Supplement Article

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

October 26, 2018

Are you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement...

Daniel E. Kremens, Rajesh Pahwa

Supplement Article

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

January 25, 2017

Leslie Citrome

Supplement Article

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

January 25, 2017

Susan G. Kornstein

Supplement Article

Pharmacologic Treatments for Binge-Eating Disorder

January 25, 2017

Susan L. McElroy

Supplement Article

Psychological and Behavioral Treatments for Binge-Eating Disorder

January 25, 2017

Carlos M. Grilo

Recent JCP Articles on Supplement Article

Supplement Article

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

February 24, 2016

S. Charles Schulz, Sophia Vinogradov

Supplement Article

Assessing Cognitive Impairment in Patients With Schizophrenia

February 24, 2016

S. Charles Schulz, Aimee Murray

Supplement Article

Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia

February 24, 2016

Michael F. Green

Recent PCC Articles on Supplement Article

Supplement Article

Attending to Anxiety Disorders in Primary Care

October 1, 2003

Murray B. Stein

Supplement Article

Establishment of Remission Criteria for Anxiety Disorders

October 1, 2003

Mark H. Pollack, Alicia C. Doyle

Supplement Article

Gender-Specific Considerations in the Treatment of Mood Disorders in Women Across the Life Cycle

October 1, 2003

Lee S. Cohen

Featured Supplement Article Research

Rounds in the General Hospital

Clozapine, Xanomeline-Trospium, and Catatonia

August 11, 2026

Abrupt clozapine discontinuation during a cross-taper to xanomeline/trospium chloride can trigger catatonia. Learn how overlapping cholinergic mechanisms complicate this transition and how to manage withdrawal-induced catatonia.

Rika Matsuo, Matthew R. Caldwell, Warren Cheng, et al

Podcast

Feeding the Mind: Metabolism in Psychiatry with David T. Liebers, MD, MPhil, MPP

August 11, 2026

Dr. David Liebers on metabolic psychiatry: ketogenic diets, SGLT2 inhibitors, and metformin for bipolar disorder, schizophrenia, and mitochondrial dysfunction.

David T. Liebers, Ben Everett

Clinical and Practical Psychopharmacology

Relative Infant Dose for Maternal Use of Drugs During Breastfeeding

August 10, 2026

Relative infant dose is explained using a worked example, and clinically important issues in its derivation, interpretation, and application are discussed.

Chittaranjan Andrade

Supplement Article

Injectable Antipsychotics in Schizophrenia

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.

Leslie Citrome, Mark Olfson, John M. Kane, et al

Supplement Article

Pediatric Bipolar Disorder: Combination Pharmacotherapy, Adverse Effects, and Treatment of High-Risk Youth

September 15, 2016

Kiki D. Chang

Supplement Article

Diagnosis, Phenomenology, Differential Diagnosis, and Comorbidity of Pediatric Bipolar Disorder

September 15, 2016

Robert A. Kowatch

Supplement Article

Evidence-Based Family Interventions for Adolescents and Young Adults With Bipolar Disorder

September 15, 2016

David J. Miklowitz

Supplement Article

Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder

September 15, 2016

Robert L. Findling

Supplement Article

Evidence-Based Psychotherapies and Nutritional Interventions for Children With Bipolar Spectrum Disorders and Their Families

September 15, 2016

Mary A. Fristad

1 2 3 … 9 »

Supplement Article

Recently published articles about Supplement Article

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

Pharmacologic Treatments for Binge-Eating Disorder

Psychological and Behavioral Treatments for Binge-Eating Disorder

Recent JCP Articles on Supplement Article

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

Assessing Cognitive Impairment in Patients With Schizophrenia

Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia

Recent PCC Articles on Supplement Article

Attending to Anxiety Disorders in Primary Care

Establishment of Remission Criteria for Anxiety Disorders

Gender-Specific Considerations in the Treatment of Mood Disorders in Women Across the Life Cycle

Featured Supplement Article Research

Clozapine, Xanomeline-Trospium, and Catatonia

Feeding the Mind: Metabolism in Psychiatry with David T. Liebers, MD, MPhil, MPP

Relative Infant Dose for Maternal Use of Drugs During Breastfeeding

ELSEWHERE:

FOLLOW US:

Supplement Article

Recently published articles about Supplement Article

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

Pharmacologic Treatments for Binge-Eating Disorder

Psychological and Behavioral Treatments for Binge-Eating Disorder

Recent JCP Articles on Supplement Article

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

Assessing Cognitive Impairment in Patients With Schizophrenia

Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia

Recent PCC Articles on Supplement Article

Attending to Anxiety Disorders in Primary Care

Establishment of Remission Criteria for Anxiety Disorders

Gender-Specific Considerations in the Treatment of Mood Disorders in Women Across the Life Cycle

Featured Supplement Article Research

Clozapine, Xanomeline-Trospium, and Catatonia

Feeding the Mind: Metabolism in Psychiatry with David T. Liebers, MD, MPhil, MPP

Relative Infant Dose for Maternal Use of Drugs During Breastfeeding

Injectable Antipsychotics in Schizophrenia

Pediatric Bipolar Disorder: Combination Pharmacotherapy, Adverse Effects, and Treatment of High-Risk Youth

Diagnosis, Phenomenology, Differential Diagnosis, and Comorbidity of Pediatric Bipolar Disorder

Evidence-Based Family Interventions for Adolescents and Young Adults With Bipolar Disorder

Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder

Evidence-Based Psychotherapies and Nutritional Interventions for Children With Bipolar Spectrum Disorders and Their Families

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles